Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines?

Area of Science:

• Cardiology
• Clinical Research
• Interventional Cardiology

Background:

• Cardiogenic shock (CS) is a severe complication of acute coronary syndromes (ACS).
• Current guidelines recommend an aggressive invasive approach for managing CS complicating ACS.
• Implementation of these guidelines is crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the adherence to established guidelines for the treatment of cardiogenic shock (CS) in patients with acute coronary syndromes (ACS).
• To assess the utilization of key interventions such as coronary angiography, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and intra-aortic balloon pump (IABP) in ACS patients with and without CS.

Main Methods:

• Analysis of data from the Euro-Heart-Survey-ACS, including 10,136 patients.
• Comparison of treatment strategies (coronary angiography, PCI, CABG, IABP) between patients with and without CS.
• Stratification of analysis based on patient age and ST-elevation ACS status.

Main Results:

• CS occurred in 5.4% of ACS patients, with 28.6% presenting with CS.
• CS patients were more likely to receive IABP (17.7% vs 0.8%) and PCI (40.8% vs 31.8%), particularly younger patients.
• In-hospital mortality was significantly higher in CS patients (52.1%) compared to non-CS patients (2.0%).
• Only 41.4% of ST-elevation ACS patients presenting with CS received reperfusion therapy.

Conclusions:

• Contemporary management of CS in ACS is associated with prohibitively high mortality rates.
• There is poor implementation of guidelines advocating an aggressive invasive strategy, evidenced by low revascularization and IABP rates.
• Improved adherence to guidelines for ACS patients who develop CS is essential to potentially improve clinical outcomes.